5-FU-based chemotherapy remains the gold standard of first-line treatment for colon cancer, which exerts its cytotoxicity on cancer cells via inhibition of thymidylate synthase (TS) and incorporation of its metabolites into DNA and RNA (Longley et al., 2003). The gene discussed is TYMS; the disease is colonic neoplasm.